Direct monitoring of verapamil level in exhaled breath condensate samples by fluorimetric assay

Direct monitoring of verapamil level in exhaled breath condensate samples by fluorimetric assay


چاپ صفحه
پژوهان
صفحه نخست سامانه
نویسندگان
نویسندگان
اطلاعات تفضیلی
اطلاعات تفضیلی
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: فریبا پورکریم , ابوالقاسم جویبان , الهه رحیم پور

عنوان کنگره / همایش: بیست و یکمین سمینار دانشجویان داروسازی , Iran (Islamic Republic) , اهواز , 2018

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله فریبا پورکریم
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات کاربردی دارویی
کد مقاله 69008
عنوان فارسی مقاله Direct monitoring of verapamil level in exhaled breath condensate samples by fluorimetric assay
عنوان لاتین مقاله Direct monitoring of verapamil level in exhaled breath condensate samples by fluorimetric assay
نوع ارائه پوستر
عنوان کنگره / همایش بیست و یکمین سمینار دانشجویان داروسازی
نوع کنگره / همایش ملی
کشور محل برگزاری کنگره/ همایش Iran (Islamic Republic)
شهر محل برگزاری کنگره/ همایش اهواز
سال انتشار/ ارائه شمسی 1396
سال انتشار/ارائه میلادی 2018
تاریخ شمسی شروع و خاتمه کنگره/همایش 1396/12/15 الی 1396/12/18
آدرس لینک مقاله/ همایش در شبکه اینترنت
آدرس علمی (Affiliation) نویسنده متقاضی Drug Applied Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

نویسندگان
hide/show

نویسنده نفر چندم مقاله
فریبا پورکریماول
ابوالقاسم جویباندوم
الهه رحیم پورسوم

اطلاعات تفضیلی
hide/show

عنوان متن
کلمات کلیدیVerapamil, Fluorescence enhancement, SDS, Exhaled breath condensate
خلاصه مقالهIntroduction and background: Verapamil is L-type calcium channel blocker widely used in the treatment of angina, arrhythmia, hypertension, cardiomyopathies, cluster headaches and modifying agent in tumors. It is necessary for future individualized patient treatment to develop a simple, rapid and highly sensitive method for the monitoring of verapamil doses in biological fluids. Exhaled breath condensate (EBC) sampling, as a fairly easily accessible matrix, is easy, repeatable, unassociated with side effects and any appreciable discomfort or risk to the subject. The assay method is based on using of a rigidity–induced material which eliminated collisional quenching and vibrational modes responsible for nonradiative decay. This process produced an enhancement in the emission intensity of verapamil, which made it possible to develop a sensitive bioanalytical methodologies for direct verapamil quantification in biological fluids. Methods: An aliquot of EBC sample solution containing verapamil was transferred into a 2 ml vial, 80 µl of SDS solution was added. The solution was diluted with deionized water to 0.5 ml and mixed well. After 15 min the fluorescence intensity was measured at 310 nm with excitation at 280 nm. Results: The important parameters influencing the analytical signal in experimental steps were investigated and optimized. Under the optimized experimental conditions, the calibration graph was linear in the range of 0.02−12.00 µg.mL−1 with a detection limit of 0.008 µg.mL−1. Discussion and Conclusion: In this research, we reported an enhanced fluorimetric assay for the direct monitoring of verapamil in exhaled breath condensate. Advantages of this method is utilizing a simple fluorimetery detection include the minimal time required to analyze samples without any sample preparation steps. The obtained sensitivity is adequate for single dose pharmacokinetic studies to be properly performed.

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Direct monitoring of verapamil.pdf1398/06/28594920دانلود
certificate.Direct monitoring of verapamil.pdf1398/06/28467191دانلود